251 related articles for article (PubMed ID: 22136295)
1. Activated T cells modulate immunosuppression by embryonic-and bone marrow-derived mesenchymal stromal cells through a feedback mechanism.
Lin W; Oh SK; Choo AB; George AJ
Cytotherapy; 2012 Mar; 14(3):274-84. PubMed ID: 22136295
[TBL] [Abstract][Full Text] [Related]
2. Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell/extracellular matrix complex induces mouse calvarial bone regeneration.
Takeshita K; Motoike S; Kajiya M; Komatsu N; Takewaki M; Ouhara K; Iwata T; Takeda K; Mizuno N; Fujita T; Kurihara H
Stem Cell Res Ther; 2017 Apr; 8(1):101. PubMed ID: 28446226
[TBL] [Abstract][Full Text] [Related]
3. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells.
Haniffa MA; Wang XN; Holtick U; Rae M; Isaacs JD; Dickinson AM; Hilkens CM; Collin MP
J Immunol; 2007 Aug; 179(3):1595-604. PubMed ID: 17641026
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
5. Human mesenchymal stromal cells transiently increase cytokine production by activated T cells before suppressing T-cell proliferation: effect of interferon-γ and tumor necrosis factor-α stimulation.
Cuerquis J; Romieu-Mourez R; François M; Routy JP; Young YK; Zhao J; Eliopoulos N
Cytotherapy; 2014 Feb; 16(2):191-202. PubMed ID: 24438900
[TBL] [Abstract][Full Text] [Related]
6. Human embryonic stem cell-derived mesenchymal stromal cells ameliorate collagen-induced arthritis by inducing host-derived indoleamine 2,3 dioxygenase.
Gonzalo-Gil E; Pérez-Lorenzo MJ; Galindo M; Díaz de la Guardia R; López-Millán B; Bueno C; Menéndez P; Pablos JL; Criado G
Arthritis Res Ther; 2016 Apr; 18():77. PubMed ID: 27036118
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
[TBL] [Abstract][Full Text] [Related]
8. Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.
Salem B; Miner S; Hensel NF; Battiwalla M; Keyvanfar K; Stroncek DF; Gee AP; Hanley PJ; Bollard CM; Ito S; Barrett AJ
Cytotherapy; 2015 Dec; 17(12):1675-86. PubMed ID: 26422657
[TBL] [Abstract][Full Text] [Related]
9. Human Adipose Tissue-Derived Stromal Cells Suppress Human, but Not Murine Lymphocyte Proliferation, via Indoleamine 2,3-Dioxygenase Activity.
Torres Crigna A; Uhlig S; Elvers-Hornung S; Klüter H; Bieback K
Cells; 2020 Nov; 9(11):. PubMed ID: 33167329
[TBL] [Abstract][Full Text] [Related]
10. Human foreskin fibroblasts exert immunomodulatory properties by a different mechanism to bone marrow stromal/stem cells.
Wada N; Bartold PM; Gronthos S
Stem Cells Dev; 2011 Apr; 20(4):647-59. PubMed ID: 20712449
[TBL] [Abstract][Full Text] [Related]
11. DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects: A potential role of adenosine.
Sangiorgi B; De Freitas HT; Schiavinato JL; Leão V; Haddad R; Orellana MD; Faça VM; Ferreira GA; Covas DT; Zago MA; Panepucci RA
Cytotherapy; 2016 Jul; 18(7):846-59. PubMed ID: 27260206
[TBL] [Abstract][Full Text] [Related]
12. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact.
Ciccocioppo R; Cangemi GC; Kruzliak P; Gallia A; Betti E; Badulli C; Martinetti M; Cervio M; Pecci A; Bozzi V; Dionigi P; Visai L; Gurrado A; Alvisi C; Picone C; Monti M; Bernardo ME; Gobbi P; Corazza GR
Stem Cell Res Ther; 2015 Jul; 6(1):137. PubMed ID: 26206376
[TBL] [Abstract][Full Text] [Related]
14. Human graft-derived mesenchymal stromal cells potently suppress alloreactive T-cell responses.
de Mare-Bredemeijer EL; Mancham S; Verstegen MM; de Ruiter PE; van Gent R; O'Neill D; Tilanus HW; Metselaar HJ; de Jonge J; Kwekkeboom J; Hall SR; van der Laan LJ
Stem Cells Dev; 2015 Jun; 24(12):1436-47. PubMed ID: 25744002
[TBL] [Abstract][Full Text] [Related]
15. [Mesenchymal stem cells and their immunological properties].
Lisianyĭ MI
Fiziol Zh (1994); 2013; 59(3):126-34. PubMed ID: 23957174
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal stem cells favor the immunosuppressive T cells skewing in a Helicobacter pylori model of gastric cancer.
Lin R; Ma H; Ding Z; Shi W; Qian W; Song J; Hou X
Stem Cells Dev; 2013 Nov; 22(21):2836-48. PubMed ID: 23777268
[TBL] [Abstract][Full Text] [Related]
17. Immunoregulatory Effects of Mesenchymal Stem Cell-Derived Extracellular Vesicles on T Lymphocytes.
Del Fattore A; Luciano R; Pascucci L; Goffredo BM; Giorda E; Scapaticci M; Fierabracci A; Muraca M
Cell Transplant; 2015; 24(12):2615-27. PubMed ID: 25695896
[TBL] [Abstract][Full Text] [Related]
18. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-γ licensing.
François M; Copland IB; Yuan S; Romieu-Mourez R; Waller EK; Galipeau J
Cytotherapy; 2012 Feb; 14(2):147-52. PubMed ID: 22029655
[TBL] [Abstract][Full Text] [Related]
19. Canine placenta: A promising potential source of highly proliferative and immunomodulatory mesenchymal stromal cells?
Saulnier N; Loriau J; Febre M; Robert C; Rakic R; Bonte T; Buff S; Maddens S
Vet Immunol Immunopathol; 2016 Mar; 171():47-55. PubMed ID: 26964717
[TBL] [Abstract][Full Text] [Related]
20. Human embryonic stem cell derived-mesenchymal stem cells: an alternative mesenchymal stem cell source for regenerative medicine therapy.
Gadkari R; Zhao L; Teklemariam T; Hantash BM
Regen Med; 2014; 9(4):453-65. PubMed ID: 25159063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
